We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
3
Latest news
Atlas Venture 2024 Year In Review
Find out more
ALS-focused Trace Neuroscience launches with $100 million in capital
Find out more
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

Discover Portfolio Team
~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

70

Startups launched from the Atlas incubator

~ Measuring our impact

40

IPOs

~ Measuring our impact

34

M&A Exits

01